←Back to Expert Scholars
Translational Medicine / 转化医学GIST, Sarcoma Clinical Trials
Suzanne George
MD
🏢Dana Farber Cancer Institute🌐USA
Chief Division of Sarcoma
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Suzanne George led the INVICTUS trial of ripretinib in fourth line GIST that led to FDA approval of this novel KIT switch control inhibitor. She directs sarcoma at Dana Farber and runs multicenter GIST clinical trials. Her work advances later line treatment options for refractory GIST.
Share:
🧪Research Fields 研究领域
GIST
sarcoma
ripretinib
INVICTUS trial
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Suzanne George 的研究动态
Follow Suzanne George's research updates
留下邮箱，当我们发布与 Suzanne George（Dana Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment